Peripheral T-cell Lymphoma Therapy CD4CAR Granted Orphan Status by FDA
News
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to iCell Gene Therapeutics‘ Chimeric Antigen Receptor (CAR) engineered T-cells targeting CD4 (CD4CAR) for the treatment of peripheral T-cell lymphoma (PTCL). ... Read more